102 related articles for article (PubMed ID: 37743336)
1. [Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System].
Nagai K; Fujii M
No Shinkei Geka; 2023 Sep; 51(5):845-857. PubMed ID: 37743336
[TBL] [Abstract][Full Text] [Related]
2. Schwannomatosis: a Realm Reborn: year one.
Planet M; Kalamarides M; Peyre M
Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
[TBL] [Abstract][Full Text] [Related]
3. New classification and approaches to the treatment of schwannomatosis.
Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
[TBL] [Abstract][Full Text] [Related]
4. [Malignant melanotic nerve sheath tumor of the posterior mediastinum].
Buero A; Olivera Lopez SB; Tchercansky A; Pankl LG; Chimondeguy DJ; Samudio M; Mendez J; Lyons GA
Medicina (B Aires); 2024; 84(2):324-328. PubMed ID: 38683517
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas.
Peyre M; Gaudric J; Bernat I; André A; Couture T; Kalamarides M
Neurosurg Rev; 2023 Oct; 46(1):275. PubMed ID: 37857782
[TBL] [Abstract][Full Text] [Related]
6. Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates.
Agarwal A; Bathla G; Soni N; Desai A; Ajmera P; Rao D; Gupta V; Vibhute P
AJNR Am J Neuroradiol; 2024 Feb; 45(2):128-138. PubMed ID: 37945522
[TBL] [Abstract][Full Text] [Related]
7. Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2.
Kotch C; Brosius SN; De Raedt T; Fisher MJ
Pediatr Neurosurg; 2023; 58(5):267-280. PubMed ID: 36746138
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.
Thompson HL; Grabowski J; Franklin B; Koetsier KS; Welling DB
Clin Trials; 2024 Feb; 21(1):18-28. PubMed ID: 38321701
[TBL] [Abstract][Full Text] [Related]
9. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
10. What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?
Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; de Jong D; Gratzinger D; Lim MS; Nicolae A; Ott G; Rosenwald A; Schuh A; Siebert R;
J Hematop; 2024 Jun; 17(2):71-89. PubMed ID: 38683440
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Hepatic Schwannoma in the Setting of Schwannomatosis.
Le MA; Shi R; Geraghty J; Zayat V; Parikh J
Cureus; 2024 Feb; 16(2):e54705. PubMed ID: 38523988
[TBL] [Abstract][Full Text] [Related]
12. Malignant Melanotic Nerve Sheath Tumors: A Review of Clinicopathologic and Molecular Characteristics.
Hammad RM
J Microsc Ultrastruct; 2023; 11(3):125-129. PubMed ID: 38025185
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of the 5th edition WHO classification of adrenal cortical tumors].
Zhang LK; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):16-21. PubMed ID: 38178741
[TBL] [Abstract][Full Text] [Related]
14. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
15. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.
Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; Jong D; Gratzinger D; Lim MS; Naresh KN; Nicolae A; Ott G; Rosenwald A; Schuh A; Siebert R
Leuk Lymphoma; 2024 Apr; 65(4):413-429. PubMed ID: 38189838
[TBL] [Abstract][Full Text] [Related]
16. Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next.
Komori T
Brain Tumor Pathol; 2024 Jan; 41(1):1-3. PubMed ID: 38113018
[No Abstract] [Full Text] [Related]
17. [Classical pathology and basic concepts of the current WHO classification (5th edition) of central nervous system tumors].
Scheich B; Rajnai H
Magy Onkol; 2023 Dec; 67(4):289-303. PubMed ID: 38109508
[TBL] [Abstract][Full Text] [Related]
18. Culture of attenuated
Ahmed SG; Oliva G; Shao M; Mekalanos JJ; Brenner GJ
Hum Vaccin Immunother; 2023 Aug; 19(2):2262639. PubMed ID: 37786375
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis.
Fernandez-Valle C; Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin H
Res Sq; 2023 Oct; ():. PubMed ID: 37886501
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
